Covered recipient · General Payments record
EDWARD J NAVAS-NAZARIO
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2018–2023
$2,526.87
- Reported across 144 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $205.82 | 11 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $64.79 | 2 |
| PFIZER INC. | $59.35 | 4 |
| ABBVIE INC. | $30.47 | 2 |
| Novo Nordisk AS | $20.78 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.80 | 1 |
| Acerta Pharma LLC | $13.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.60 | 04/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997990923 | CMS |
| ABBVIE INC. | $15.87 | 06/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997990925 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.63 | 09/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015860651 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.80 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996586111 | CMS |
| GlaxoSmithKline, LLC. | $33.46 | 06/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002021351 | CMS |
| GlaxoSmithKline, LLC. | $31.33 | 09/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002021235 | CMS |
| Novo Nordisk Inc | $20.78 | 06/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002231206 | CMS |
| PFIZER INC. | $14.53 | 04/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050347053 | CMS |
| PFIZER INC. | $18.56 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050684573 | CMS |
| PFIZER INC. | $12.76 | 07/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050623245 | CMS |
| PFIZER INC. | $13.50 | 09/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050448451 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.